Smoking Study Finds Racial Disparities
Posted on: Saturday, 28 January 2006, 09:00 CST
By Alicia Chang
Blacks who smoke up to a pack a day are far more likely than whites who smoke similar amounts to develop lung cancer, suggesting genes may help explain the racial differences long seen in the disease, researchers say.
The largest study ever done on the subject also found that Hispanic and Asian smokers were less likely than black smokers to develop the disease -- at least up to a point. The racial differences disappeared among heavy smokers, or those who puffed more than a pack and a half per day.
Doctors have long known that blacks are substantially more likely than whites to develop lung cancer and more likely to die from it. But the reasons for the disparity are unclear.
Some say the difference is a matter of genetics, while others contend smoking habits may play a role. For example, researchers say blacks tend to puff more deeply than whites, which may expose them to more carcinogens. Smoking rates are also slightly higher among blacks, but whites tend to smoke more cigarettes a day.
In the latest study -- published in today's New England Journal of Medicine -- researchers compared the lung cancer risk among ethnic groups who smoked the same amount.
While the study did not address the possible reasons for the racial disparity, lead researcher Christopher Haiman, an assistant professor of preventive medicine at the University of Southern California, said the findings suggest genes may be one of the factors that explain the phenomenon.
The study involved more than 180,000 people, more than half of them minorities. Patients filled out questionnaires about their smoking habits, diet and other personal information.
Researchers from USC and the University of Hawaii analyzed lung cancer cases over an eight-year period. After adjusting for diet, education and other factors, the researchers found that whites who smoked up to a pack a day had a 43 percent to 55 percent lower risk of lung cancer than blacks who smoked the same amount. Hispanics and Japanese-Americans were 60 percent to 80 percent less likely than blacks to develop the disease.
The effect of race on the risk of disease is controversial, in part because race was used to discriminate in human experiments. Now it is increasingly being exploited in the emerging field of medicine that tailors drugs to a person's genetics. Last year, the Food and Drug Administration approved a heart-failure drug specifically for blacks. Different response rates also have been seen among certain ethnic groups to cancer drugs.
Source: Buffalo News
Related Articles
- Mersana's Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
- Response Genetics, Inc. Announced Results of Pre-Clinical Studies on Gene Expression at the American Association for Cancer Research 2008 Annual Meeting
- Rexinoid Developed By NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
- Spatbox.Com Announces Launch to Raise Funds for Pancreatic Cancer Research
- Celebrex May Help Fight Colon Cancer, Researchers Say
- African-Americans Disproportionately Affected By Lung Disease; Lung Cancer Is Top 3 Killer
- Scott & White Cancer Researcher Signs Contract to Help Develop Drugs
- Interstitial Lung Disease, Lung Cancer, Lung Transplantation, Pulmonary Vascular Disorders, and Sleep-Disordered Breathing in AJRCCM in 2004
- Lung Disease Research Fear
- Study Finds Fewer Cancer Research Deaths
User Comments (0)


RSS Feeds